South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

Czech Republic-based Zentiva Pharma, a generics and over-the-counter medicines company that is wholly-owned by private equity firm Advent International and was formerly a subsidiary of Sanofi, has ...

Privately-held Cambridge, USA-based biotech Gensaic announced a potentially lucrative license and discovery collaboration ...

Steven Højlund is a Danish writer, Youtuber, and social scientist (Ph.D.) based in Copenhagen. He has written several books ...

The trade deal between Vietnam and the EU has been making significant impacts on the home pharma market, driven by tariff ...

Gensaic arbejder med teknologi, der hjælper medicin med at nå specifikke organer. Novo ser »så stort potentiale« i fremgangsmåden – både i de sygdomme, der kan adresseres, og de behandlingsmetoder, ...

Denmark's Salling Group will highlight European products in its stores with a special 'black star' label on electronic price ...

AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based ...

A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with ...

Total deal value of up to $354 million in upfront, development, and commercial milestone payments per target plus tiered ...

Per the terms of the deal, AbbVie will lead the development and commercialization of the obesity drug developed by Gubra.

Technology and Consumer Discretionary are the only two sectors down in the first two months of this year, among the 11 market ...